1,300 results on '"A, Leguerrier"'
Search Results
102. A probabilistic approach of flow-balanced network based on Markov chains
- Author
-
Leguerrier, Delphine, Bacher, Cédric, Benoît, Eric, and Niquil, Nathalie
- Published
- 2006
- Full Text
- View/download PDF
103. Comparative analysis of the food webs of two intertidal mudflats during two seasons using inverse modelling: Aiguillon Cove and Brouage Mudflat, France
- Author
-
Degré, Delphine, Leguerrier, Delphine, Armynot du Chatelet, Eric, Rzeznik, Jadwiga, Auguet, Jean-Christophe, Dupuy, Christine, Marquis, Elise, Fichet, Denis, Struski, Caroline, Joyeux, Emmanuel, Sauriau, Pierre-Guy, and Niquil, Nathalie
- Published
- 2006
- Full Text
- View/download PDF
104. Prise en charge de la plaque aortique emboligène
- Author
-
Abouliatim, I., primary, de Latour, B., additional, and Leguerrier, A., additional
- Published
- 2009
- Full Text
- View/download PDF
105. Traitement chirurgical des ruptures aiguës de l’isthme aortique
- Author
-
Langanay, T., primary, Flécher, E., additional, and Leguerrier, A., additional
- Published
- 2009
- Full Text
- View/download PDF
106. Prediction of left ventricular ejection fraction 6 months after surgical correction of organic mitral regurgitation: the value of exercise echocardiography and deformation imaging
- Author
-
Donal, Erwan, Mascle, Sophie, Brunet, Anne, Thebault, Christophe, Corbineau, Herve, Laurent, Marcel, Leguerrier, Alain, and Mabo, Philippe
- Published
- 2012
- Full Text
- View/download PDF
107. Registry of Transcatheter Aortic-Valve Implantation in High-Risk Patients
- Author
-
Gilard, Martine, Eltchaninoff, Hélène, Iung, Bernard, Donzeau-Gouge, Patrick, Chevreul, Karine, Fajadet, Jean, Leprince, Pascal, Leguerrier, Alain, Lievre, Michel, Prat, Alain, Teiger, Emmanuel, Lefevre, Thierry, Himbert, Dominique, Tchetche, Didier, Carrié, Didier, Albat, Bernard, Cribier, Alain, Rioufol, Gilles, Sudre, Arnaud, Blanchard, Didier, Collet, Frederic, Santos, Pierre Dos, Meneveau, Nicolas, Tirouvanziam, Ashok, Caussin, Christophe, Guyon, Philippe, Boschat, Jacques, Le Breton, Herve, Collart, Frederic, Houel, Remi, Delpine, Stephane, Souteyrand, Geraud, Favereau, Xavier, Ohlmann, Patrick, Doisy, Vincent, Grollier, Gilles, Gommeaux, Antoine, Claudel, Jean-Philippe, Bourlon, Francois, Bertrand, Bernard, Van Belle, Eric, and Laskar, Marc
- Published
- 2012
- Full Text
- View/download PDF
108. Assessment of Patient-Led or Physician-Driven Continuous Glucose Monitoring in Patients With Poorly Controlled Type 1 Diabetes Using Basal-Bolus Insulin Regimens: A 1-year multicenter study
- Author
-
Riveline, Jean-Pierre, Schaepelynck, Pauline, Chaillous, Lucy, Renard, Eric, Sola-Gazagnes, Agnès, Penfornis, Alfred, Tubiana-Rufi, Nadia, Sulmont, Véronique, Catargi, Bogdan, Lukas, Céline, Radermecker, Régis P., Thivolet, Charles, Moreau, François, Benhamou, Pierre-Yves, Guerci, Bruno, Leguerrier, Anne-Marie, Millot, Luc, Sachon, Claude, Charpentier, Guillaume, and Hanaire, Hélène
- Published
- 2012
- Full Text
- View/download PDF
109. P429New indices for prediction of the left ventricular ejection fraction after correction of an organic mitral regurgitation
- Author
-
Donal, E, Mascle, S, Thebault, C, Veillard, D, Hamonic, H, Leguerrier, A, and Corbineau, H
- Published
- 2011
110. Improved diagnosis of post-operative myocardial infarction by contrast echocardiography after coronary artery bypass graft surgery
- Author
-
Schnell, Frederic, Donal, Erwan, Bernard, Anne, Thebault, Christophe, Lelong, Bernard, Kervio, Gaelle, Flecher, Erwan, Corbineau, Herve, Le Breton, Herve, and Leguerrier, Alain
- Published
- 2011
- Full Text
- View/download PDF
111. Evolution of the Radiation Therapist Role in a Multidisciplinary Palliative Radiation Oncology Clinic
- Author
-
LeGuerrier, Bronwen, Huang, Fleur, Spence, Winter, Rose, Brenda, Middleton, Jacqueline, Palen, Megan, Thvone, Kitta, Ravji, Shazma, Danielson, Brita, Severin, Diane, Chu, Karen P., and Fairchild, Alysa
- Published
- 2019
- Full Text
- View/download PDF
112. Reply to a brief comment on the past and present of surgical treatment of cardiac wounds
- Author
-
Flécher, Erwan, primary, Leguerrier, Alain, additional, and Nesseler, Nicolas, additional
- Published
- 2020
- Full Text
- View/download PDF
113. An odyssey of suturing cardiac wounds: Lessons from the past
- Author
-
Flécher, Erwan, primary, Leguerrier, Alain, additional, and Nesseler, Nicolas, additional
- Published
- 2020
- Full Text
- View/download PDF
114. The Odyssey of suturing cardiac wounds: lessons from the past.
- Author
-
Flecher, Erwan, primary, Leguerrier, Alain, additional, and Nesseler, Nicolas, additional
- Published
- 2020
- Full Text
- View/download PDF
115. Beckett lu par Adorno : La Catastrophe du langage comme réponse à la catastrophe historique
- Author
-
Leguerrier, Louis-Thomas, primary
- Published
- 2020
- Full Text
- View/download PDF
116. Structural and spectroscopic investigations of nine-coordinate redox active lanthanide complexes with a pincer O,N,O ligand
- Author
-
Mouchel Dit Leguerrier, D., primary, Barré, R., additional, Bryden, M., additional, Imbert, D., additional, Philouze, C., additional, Jarjayes, O., additional, Luneau, D., additional, Molloy, J. K., additional, and Thomas, F., additional
- Published
- 2020
- Full Text
- View/download PDF
117. Luminescent pro-nitroxide lanthanide complexes for the detection of reactive oxygen species
- Author
-
Barré, Richard, primary, Mouchel dit Leguerrier, Damien, additional, Fedele, Lionel, additional, Imbert, Daniel, additional, Molloy, Jennifer K., additional, and Thomas, Fabrice, additional
- Published
- 2020
- Full Text
- View/download PDF
118. Insulin pump failures are still frequent: a prospective study over 6 years from 2001 to 2007
- Author
-
Guilhem, I., Balkau, B., Lecordier, F., Malécot, J.-M., Elbadii, S., Leguerrier, A.-M., Poirier, J.-Y., Derrien, C., and Bonnet, F.
- Published
- 2009
- Full Text
- View/download PDF
119. Impact of coronary artery disease in patients undergoing transcatheter aortic valve replacement: Insights from the FRANCE-2 registry
- Author
-
Alain Leguerrier, Didier Carrié, Patrick Donzeau-Gouge, Thierry Lefèvre, Stephan Chassaing, Etienne Puymirat, Jean Fajadet, Martine Gillard, Emmanuel Teiger, Pascal Leprince, Hervé Le Breton, Michel Lievre, Eric Durand, Jean-Philippe Collet, Dominique Himbert, Didier Tchetche, Karine Chevreul, Bernard Lung, Hélène Eltchaninoff, Romain Didier, Florence Leclercq, Didier Blanchard, Vascular research center of Marseille (VRCM), Institut National de la Santé et de la Recherche Médicale (INSERM)-Aix Marseille Université (AMU), Département Cardiologie, Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Service de cardiologie [CHU Rouen], Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-CHU Rouen, Normandie Université (NU), Service de cardiologie, Université Paris Diderot - Paris 7 (UPD7)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Génétique épidémiologique et moléculaire des pathologies cardiovasculaires, Université Pierre et Marie Curie - Paris 6 (UPMC)-IFR14-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Rouen, Service de chirurgie thoracique cardiaque et vasculaire [Rennes] = Thoracic and Cardiovascular Surgery [Rennes], CHU Pontchaillou [Rennes], CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Clinique Pasteur, Clinique Pasteur [Toulouse], Institut Mondor de recherche biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Epidémiologie Clinique et Evaluation Economique Appliquées aux Populations Vulnérables (ECEVE (U1123 / UMR_S_1123)), Institut National de la Santé et de la Recherche Médicale (INSERM)-AP-HP Hôpital universitaire Robert-Debré [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7), Evaluation et modélisation des effets thérapeutiques, Département biostatistiques et modélisation pour la santé et l'environnement [LBBE], Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Clinique Saint Gatien, Laboratoire Traitement du Signal et de l'Image (LTSI), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Cardiovasculaire Paris Sud (ICPS), Optimisation des régulations physiologiques (ORPHY (EA 4324)), Université de Brest (UBO)-Centre Hospitalier Régional Universitaire de Brest (CHRU Brest)-Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Université de Brest (UBO), CIC Brest, Université de Brest (UBO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital de la Cavale Blanche, Edwards Lifesciences, Medtronic, Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7), Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM)-AP-HP Hôpital universitaire Robert-Debré [Paris], Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Paris Diderot - Paris 7 (UPD7)-AP-HP - Hôpital Bichat - Claude Bernard [Paris]-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP), Service de chirurgie thoracique cardiaque et vasculaire [Rennes], Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou-CHU Pontchaillou [Rennes], CHU Pitié-Salpêtrière [APHP], Maladies infectieuses et vecteurs : écologie, génétique, évolution et contrôle (MIVEGEC), Institut de Recherche pour le Développement (IRD [France-Sud])-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), Institut Brestois Santé Agro Matière (IBSAM), and Université de Brest (UBO)-Université de Brest (UBO)-Université de Brest (UBO)-Centre Hospitalier Régional Universitaire de Brest (CHRU Brest)
- Subjects
Male ,[SDV]Life Sciences [q-bio] ,medicine.medical_treatment ,CAD ,Disease ,Coronary Artery Disease ,030204 cardiovascular system & hematology ,Coronary Angiography ,Severity of Illness Index ,Coronary artery disease ,0302 clinical medicine ,Valve replacement ,Risk Factors ,Registries ,030212 general & internal medicine ,Coronary Artery Bypass ,ComputingMilieux_MISCELLANEOUS ,Aged, 80 and over ,education.field_of_study ,Incidence ,Hazard ratio ,General Medicine ,3. Good health ,Survival Rate ,Treatment Outcome ,medicine.anatomical_structure ,Aortic Valve ,Cardiology ,Female ,France ,Cardiology and Cardiovascular Medicine ,Artery ,medicine.medical_specialty ,Transcatheter aortic ,Population ,Clinical Investigations ,Revascularization ,Risk Assessment ,Transcatheter Aortic Valve Replacement ,03 medical and health sciences ,Percutaneous Coronary Intervention ,[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system ,Internal medicine ,medicine ,Humans ,In patient ,cardiovascular diseases ,education ,business.industry ,Percutaneous coronary intervention ,Aortic Valve Stenosis ,medicine.disease ,Confidence interval ,business ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology ,Follow-Up Studies - Abstract
BACKGROUND: Coronary artery disease (CAD) is common in patients undergoing transcatheter aortic valve replacement (TAVR). However, the impact of CAD distribution before TAVR on short‐ and long‐term prognosis remains unclear. HYPOTHESIS: We hypothesized that the long‐term clinical impact differs according to CAD distribution in patients undergoing TAVR using the FRench Aortic National CoreValve and Edwards (FRANCE‐2) registry. METHODS: FRANCE‐2 is a national French registry including all consecutive TAVR performed between 2010 and 2012 in 34 centers. Three‐year mortality was assessed in relation to CAD status. CAD was defined as at least 1 coronary stenosis >50%. RESULTS: A total of 4201 patients were enrolled in the registry. For the present analysis, we excluded patients with a history of coronary artery bypass. CAD was reported in 1252 patients (30%). Half of the patients presented with coronary multivessel disease. CAD extent was associated with an increase in cardiovascular risk profile and in logistic EuroSCORE (European System for Cardiac Operative Risk Evaluation) (from 19.3% ± 12.8% to 21.9% ± 13.5%, P < 0.001). Mortality at 30 days and 3 years was 9% and 44%, respectively, in the overall population. In multivariate analyses, neither the presence nor the extent of CAD was associated with mortality at 3 years (presence of CAD, hazard ratio [HR]: 0.90; 95% confidence interval [CI]: 0.78‐1.07). A significant lesion of the left anterior descending (LAD) was associated with higher 3‐year mortality (HR: 1.42; 95% CI: 1.10‐1.87). CONCLUSIONS: CAD is not associated with decreased short‐ and long‐term survival in patients undergoing TAVR. The potential deleterious effect of LAD disease on long‐term survival and the need for revascularization before or at the time of TAVR should be validated in a randomized control trial.
- Published
- 2017
- Full Text
- View/download PDF
120. Texte 1 : rappels sur l’hyperglycémie
- Author
-
Igor Tauveron, Sophie Jacqueminet, Anne-Marie Leguerrier, Gaëlle Cheisson, Alexandre Ouattara, Dan Benhamou, Bogdan Nicolescu-Catargi, Paul Valensi, Carole Ichai, and Emmanuel Cosson
- Subjects
2. Zero hunger ,Gynecology ,03 medical and health sciences ,medicine.medical_specialty ,0302 clinical medicine ,Anesthesiology and Pain Medicine ,030202 anesthesiology ,business.industry ,Basal bolus ,medicine ,030209 endocrinology & metabolism ,business ,3. Good health - Abstract
Resume Le diabete sucre correspond a une elevation chronique de la glycemie liee a une insulinoresistance et/ou une insulinopenie. Son diagnostic repose actuellement sur une mesure de la glycemie a jeun ≥ 1,26 g/L ou dans certains pays sur un dosage d’hemoglobine glyquee (HbA1c) > 6,5 %. Il existe plusieurs formes de diabete. Le diabete de type 2 (DT2) est le plus frequent et s’observe chez des patients presentant des facteurs de risque. Le diabete de type 1 (DT1) est lie a une destruction auto-immune des cellules beta-pancreatiques conduisant a une insulinopenie. La carence en insuline entraine une acidocetose diabetique en quelques heures. Les diabetes « pancreatiques » font suite a certaines pancreatopathies et peuvent conduire a une insulinopenie. Les traitements du diabete reposent pour le DT2 sur les medicaments non insuliniques et sur les insulines quand le diabete devient insulinorequerant. Pour le DT1, le traitement repose sur les insulines lentes et les analogues ultrarapides de l’insuline selon le schema « basal-bolus » ou par la delivrance en continu en sous-cutane par l’intermediaire d’une pompe. Pour les patients presentant une dysglycemie meconnue, il faut rechercher s’il s’agit d’une dysglycemie preexistante ou une hyperglycemie de stress. Cette derniere est definie comme une hyperglycemie transitoire chez des patients non diabetiques anterieurement et qui presentent une maladie aigue ou beneficient d’une intervention chirurgicale. Son importance est fonction du type de chirurgie, de l’agressivite du geste et de sa duree. Elle conduit a une insulinoresistance peripherique et constitue un facteur pronostique independant de morbi-mortalite.
- Published
- 2017
- Full Text
- View/download PDF
121. Texte 2 : période préopératoire
- Author
-
Paul Valensi, Sophie Jacqueminet, Carole Ichai, Alexandre Ouattara, Igor Tauveron, Dan Benhamou, Bogdan Nicolescu-Catargi, Emmanuel Cosson, Anne-Marie Leguerrier, and Gaëlle Cheisson
- Subjects
03 medical and health sciences ,0302 clinical medicine ,Anesthesiology and Pain Medicine ,030209 endocrinology & metabolism ,030204 cardiovascular system & hematology ,3. Good health - Abstract
Resume En preoperatoire, il est necessaire d’evaluer l’equilibre glycemique du diabetique. Cette evaluation repose sur l’hemoglobine glyquee (HbA1c) et les glycemies capillaires recentes. Une adaptation des traitements peut etre necessaire avant la chirurgie. Les complications specifiques du diabete doivent etre recherchees. La gastroparesie cree un risque de stase et d’inhalation a l’induction anesthesique imposant une induction type « estomac plein ». L’atteinte cardiaque se divise en plusieurs entites. La maladie coronaire se distingue par l’ischemie myocardique silencieuse, presente chez 30 a 50 % des diabetiques de type 2. La cardiomyopathie diabetique est une cause authentifiee d’insuffisance cardiaque. Enfin, la neuropathie autonome cardiaque, rarement symptomatique doit etre recherchee car a l’origine d’une augmentation des evenements cardiovasculaires et du risque de mort subite. Plusieurs signes permettent de la suspecter. Sa confirmation impose une surveillance perioperatoire rapprochee. La maladie renale chronique diabetique aggrave le risque d’insuffisance renale aigue perioperatoire. L’evaluation du debit de filtration glomerulaire est indispensable en pre operatoire. La derniere etape de la consultation s’interesse a la gestion des traitements hypoglycemiants. La perfusion glucosee en preoperatoire n’est pas necessaire si le patient ne recoit pas d’insuline. Les medicaments non insuliniques ne sont pas administres le matin de l’intervention sauf la metformine qui n’est pas administree des la veille au soir. Les insulines sont injectees la veille au soir aux posologies habituelles. La pompe a insuline est maintenue jusqu’a l’arrivee au bloc operatoire. On rappelle qu’une carence en insuline chez un diabetique de type 1 conduit a une acidocetose en quelques heures.
- Published
- 2017
- Full Text
- View/download PDF
122. Texte 4: période postopératoire
- Author
-
Emmanuel Cosson, Alexandre Ouattara, Gaëlle Cheisson, Paul Valensi, Carole Ichai, Bogdan Nicolescu-Catargi, Anne-Marie Leguerrier, Igor Tauveron, Dan Benhamou, and Sophie Jacqueminet
- Subjects
Gynecology ,03 medical and health sciences ,medicine.medical_specialty ,0302 clinical medicine ,Anesthesiology and Pain Medicine ,business.industry ,Basal bolus ,medicine ,030209 endocrinology & metabolism ,030212 general & internal medicine ,business ,3. Good health - Abstract
Resume Le relais de l’insuline IVSE administree en peroperatoire constitue un element essentiel de la prise en charge du patient diabetique en postoperatoire. Le schema basal-bolus est le plus adapte compte tenu des apports nutritionnels et des besoins variables en insuline. Il reproduit la physiologie d’un pancreas normal : (i) une insuline lente (= basal) qui doit relayer sans delai l’insuline IVSE simulant la secretion basale ; (ii) des insulines ultrarapides pour simuler la secretion prandiale (= bolus pour le repas) ; et (iii) pour permettre la correction d’une eventuelle hyperglycemie (= bolus correcteur). Des schemas sont proposes pour aider au calcul de posologies pour le passage de l’insuline intraveineuse a l’insuline sous-cutanee et pour le schema basal-bolus. La reprise en postoperatoire d’une pompe a insuline impose que le patient soit autonome. Sinon, il est obligatoire de mettre en place un schema basal-bolus sans delai a l’arret de l’insuline intraveineuse. La surveillance glycemique doit etre poursuivie en postoperatoire. Les hypoglycemies et les hyperglycemies graves doivent etre recherchees. Devant une hypoglycemie 16,5 mmol/L (3 g/L) chez le DT1 et chez le DT2 traite par insuline, la recherche d’une cetose doit etre systematique. Chez les DT2, une hyperglycemie franche doit egalement faire evoquer une hyperosmolarite diabetique (coma hyperosmolaire). Enfin, les modalites de reprise des traitements anterieurs sont detaillees selon le type d’hyperglycemie, la fonction renale et l’equilibre du diabete en preoperatoire et durant l’hospitalisation.
- Published
- 2017
- Full Text
- View/download PDF
123. Texte 3 : période peropératoire
- Author
-
la Société francophone du diabète, Anne-Marie Leguerrier, Igor Tauveron, Bogdan Nicolescu-Catargi, Alexandre Ouattara, Gaëlle Cheisson, Dan Benhamou, Emmanuel Cosson, Sophie Jacqueminet, Paul Valensi, and Carole Ichai
- Subjects
Gynecology ,03 medical and health sciences ,medicine.medical_specialty ,0302 clinical medicine ,Anesthesiology and Pain Medicine ,030202 anesthesiology ,business.industry ,medicine ,030212 general & internal medicine ,business ,3. Good health - Abstract
Resume L’hyperglycemie perioperatoire (> 1,80 g/L ou 10 mmol/L) augmente la morbidite (notamment les infections) et la mortalite. Sa prise en charge passe par la diminution de la glycemie plus que par l’insuline. Un controle glycemique entre 0,90 et 1,80 g/L (5 a 10 mmol/L) permet d’eviter les hypoglycemies qui etaient plus frequentes lorsque la normoglycemie stricte etait recherchee. Le controle glycemique doit se poursuivre en peroperatoire. Nous proposons un protocole d’insulinotherapie IVSE chez les patients diabetiques de type 1, de type 2 si besoin ou en cas d’hyperglycemie de stress. L’arret de la pompe a insuline impose un relais immediat par insuline IVSE. Les autres elements de prise en charge peroperatoire sont detailles. Nous recommandons pour la prophylaxie des nausees et vomissements d’utiliser 4 mg de dexamethasone, plutot que 8 mg, en association a un autre antiemetique. L’emploi de l’anesthesie locoregionale (ALR), lorsqu’elle est possible, est un facteur de meilleur controle de la douleur postoperatoire et doit etre privilegie. Les besoins antalgiques sont plus eleves chez les patients ayant un equilibre glycemique de mauvaise qualite que ceux ayant un taux d’HbA1c
- Published
- 2017
- Full Text
- View/download PDF
124. EXTRACORPOREAL MEMBRANE OXYGENATION DURING ABDOMINAL AORTIC ANEURYSM SURGERY FOR HIGH CARDIAC RISK PATIENTS: P20
- Author
-
Harmouche, M., Abouliatim, I., Flecher, E., Delatour, B., Ternisien, E., Leguerrier, A., and Verhoye, J-P.
- Published
- 2009
125. Les endocardites aiguës infectieuses sévères à travers l’histoire
- Author
-
Erwan Flecher, Alain Leguerrier, Jean-Philippe Verhoye, and Simon Rouzé
- Subjects
medicine.medical_specialty ,business.industry ,General surgery ,030204 cardiovascular system & hematology ,medicine.disease ,03 medical and health sciences ,0302 clinical medicine ,030228 respiratory system ,Current management ,Cardiothoracic surgery ,Infective endocarditis ,medicine ,Endocarditis ,Cardiology and Cardiovascular Medicine ,Abscess ,business - Abstract
The history of infective endocarditis (IE) is a good example of medical progress. Initially incurable, endocarditis, when diagnosed, was synonym of death. After significant diagnostic progress, thanks to Osler's contribution especially, the first surgeries and antibacterial drugs obtained very few successful cures. We had to wait until Flamming's discovery to observe frequent cures thanks to antibiotics. Surgery manages to push possibilities of cure a bit further. However, paravalvular extensions, described since the first surgical case of IE, was a real technical matter. Thus, the second half of 20th century was devoted to overcoming this surgical challenge. In this historical review, we describe the story of severe IE, especially with paravalvular involvement, by highlighting major progress - clinical and surgical, that allows its current management.
- Published
- 2017
- Full Text
- View/download PDF
126. Les lésions cardiaques traumatiques
- Author
-
Langanay, T., Tauran, A., Vola, M., Ngo Vi, H., Ibrahim, M.S., Derieux, T., Verhoye, J.-P., Corbineau, H., Ménestret, P., and Leguerrier, A.
- Published
- 2005
- Full Text
- View/download PDF
127. No association between fear of hypoglycemia and blood glucose variability in type 1 diabetes: The cross-sectional VARDIA study
- Author
-
Fabrice Bonnet, Lucy Chaillous, Stéphanie Ragot, Matthieu Wargny, D. Gouet, Pierre Jean Saulnier, Véronique Kerlan, Bertrand Cariou, Caroline Perlemoine, Anne Marie Leguerrier, Samy Hadjadj, Gerard Fradet, Ingrid Delcourt Crespin, Linda Gonder-Frederick, Séverine Dubois, Claire Briet, Elise Gand, Matthieu Pichelin, Pierre Henri Ducluzeau, CIC - Poitiers, Université de Poitiers-Centre hospitalier universitaire de Poitiers (CHU Poitiers)-Direction Générale de l'Organisation des Soins (DGOS)-Institut National de la Santé et de la Recherche Médicale (INSERM), Physiopathologie Cardiovasculaire et Mitochondriale (MITOVASC), Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre hospitalier universitaire de Poitiers (CHU Poitiers), Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôpital Laennec, Stress Oxydant et Pathologies Métaboliques (SOPAM), Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service d'Endocrinologie (CHRU - Endocrino), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Hopital saint louis (LA ROCHELLE - Hôpital Saint Louis), CH La Rochelle, unité de recherche de l'institut du thorax UMR1087 UMR6291 (ITX), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN), and Université de Nantes (UN)
- Subjects
Adult ,Blood Glucose ,Male ,medicine.medical_specialty ,endocrine system diseases ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,[SDV]Life Sciences [q-bio] ,030209 endocrinology & metabolism ,[SDV.BC]Life Sciences [q-bio]/Cellular Biology ,030204 cardiovascular system & hematology ,Hypoglycemia ,03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,Insulin Infusion Systems ,Internal medicine ,Diabetes mellitus ,Surveys and Questionnaires ,Epidemiology ,Internal Medicine ,Medicine ,Humans ,Insulin ,ComputingMilieux_MISCELLANEOUS ,Glycemic ,Aged ,Type 1 diabetes ,business.industry ,Blood Glucose Self-Monitoring ,[SDV.BA]Life Sciences [q-bio]/Animal biology ,nutritional and metabolic diseases ,Fear ,Infusion Pumps, Implantable ,Middle Aged ,[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences ,medicine.disease ,Severe hypoglycemia ,Cross-Sectional Studies ,Diabetes Mellitus, Type 1 ,Observational study ,Female ,France ,business ,[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition - Abstract
Aims In type 1 diabetes (T1D), treatment efficacy is limited by the unpredictability of blood glucose results and glycemic variability (GV). Fear of Hypoglycemia (FOH) remains a major brake for insulin treatment optimization. We aimed to assess the association of GV with FOH in participants with T1D in an observational cross-sectional study performed in 9 French Diabetes Centres ( NCT02790060 ). Methods Participants were T1D for ≥5 years, aged 18–75 years, on stable insulin therapy for ≥3 months. The coefficient of variation (CV) of blood glucose and mean amplitude of glycemic excursions (MAGE) were used to assess GV from 7-point self-monitoring of blood glucose (SMBG). FOH was assessed using the validated French version of the Hypoglycemia Fear Survey-II (HFS-II) questionnaire. Results Among a total of 570 recruited participants, 298 were suitable for analysis: 46% women, 58% on continuous subcutaneous insulin infusion [CSII], mean age 49 ± 16 years, HbA1c 7.5 ± 0.9%, HFS-II score 67 ± 18 and 12% with recent history of severe hypoglycemia during the previous 6 months, mean CV 39.8 ± 9.7% and MAGE 119 ± 42 mg/dL. CV and MAGE did not significantly correlate with HFS-II score (R = −0.05;P = 0.457 and R = 0.08;P = 0.170). Participants with severe hypoglycemia in the previous 6 months had higher HFS scores. Participants with higher HFS scores presented more hypoglycemias during follow-up. Conclusions FOH as determined using the HFS-II questionnaire was not associated with 7-point SMBG variability in participants with T1D, but was associated with a positive history of severe hypoglycemia. Higher FOH was associated with higher frequency of hypoglycemia during follow-up.
- Published
- 2019
- Full Text
- View/download PDF
128. La figure d’Ulysse au XXe siècle : une mise en scène du rapport de force entre affect et raison
- Author
-
Leguerrier, Louis-Thomas and Cochran, Terry
- Subjects
Ulysse ,Literary ,Jérusalem ,Mediation ,Médiation ,Odysseus ,Littéraire ,Athens ,Reason ,Raison ,Figure ,Affect ,Athènes ,Jerusalem - Abstract
Cette thèse examine l’omniprésence de la figure d’Ulysse dans la conscience de soi du XXe siècle à travers ses nombreuses réécritures littéraires et philosophiques. Constatant la prolifération sans précédent de la figure d’Ulysse dans la littérature de cette période, il s’agit de montrer qu’elle incarne et met en marche une pensée qui conduit au cœur des problèmes les plus importants du siècle. La fortune littéraire et critique qu’Ulysse connaît au XXe siècle est expliquée par les modalités de la pensée qu’il véhicule, modalités qui sont éclairées par la définition d’Ulysse en tant que figure de la médiation des extrêmes. Cette pensée des extrêmes incarnée par Ulysse est définie comme une manifestation de l’esprit propre au littéraire et irréductible à la pensée conceptuelle, c’est-à-dire comme pensée littéraire. À partir de l’étude de textes littéraires du XXe siècle dans lesquels se manifeste la figure d’Ulysse, je montre que cette pensée concerne le rapport de force entre affect et raison au sein de l’esprit, la manière dont la raison se propulse à partir des affects pour ensuite être débordée par ceux-ci, dans un mouvement perpétuel qui est exemplifié par les pérégrinations d’Ulysse en quête d’un retour impossible. Ce rapport de force entre affect et raison est thématisé de manière spécifique sous la forme de la mise en scène par la figure d’Ulysse du rapport de force entre l’origine hellénique et l’origine judéo-chrétienne de la civilisation occidentale, entre raison et révélation, savoir et foi, Athènes et Jérusalem., This thesis examines the omnipresence of the Odysseus figure in twentieth century self-consciousness throughout its many literary and philosophical rewritings. Noting the unprecedented proliferation of the Odysseus figure in this period’s literature, the thesis seeks to convey the ways in which it embodies and sets in motion thinking at the core of the most important problems of the century. Odysseus’s literary and critical fortune in the twentieth century is explained by the modalities of thought which it conveys, modalities that are themselves clarified by the definition of Odysseus as a figure of the mediation between extremes. This thought of and between extremes embodied by Odysseus is defined as a manifestation of the mind proper to the literary, that is, as specifically literary thought, which is irreducible to conceptual thought. From the study of diverse literary texts of the twentieth century in which the Odysseus figure appears, I demonstrate that this particular form of thought concerns the balance of power between affect and reason within the mind, the way in which reason propels itself on the basis of affects only to become overwhelmed by them, in a perpetual movement that is exemplified by the peregrinations of Odysseus in his quest for an impossible return. This power struggle between affect and reason becomes a thematic element in the form of Odysseus’s depiction, or “mise en scène,” of the power struggle between the Hellenic and Judeo-Christian origins of Western civilization, between reason and revelation, knowledge and faith, Athens and Jerusalem.
- Published
- 2019
129. Association between sleep disturbances and fear of hypoglycemia in adults with type 1 diabetes, data from VARDIA Study
- Author
-
Gerard Fradet, A.M. Leguerrier, Samy Hadjhadj, Valentine Suteau, Véronique Kerlan, Matthieu Wargny, Linda Gonder-Frederic, Pierre-Henri Ducluzeau, D. Gouet, Claire Briet, Caroline Perlemoine, Séverine Dubois, B. Cariou, Ingrid Allix, Elise Gand, Fabrice Bonnet, Matthieu Pichelin, Isabelle Delcourt Crespin, Lucy Chaillous, Pierre-Jean Saulnier, and Stéphanie Ragot
- Subjects
Pediatrics ,medicine.medical_specialty ,Type 1 diabetes ,business.industry ,medicine ,Hypoglycemia ,business ,medicine.disease ,Association (psychology) ,Sleep in non-human animals - Published
- 2019
- Full Text
- View/download PDF
130. High-intensity transcranial magnetic stimulation reveals differential cortical contributions to prepared responses
- Author
-
Anthony N. Carlsen, Neil M. Drummond, Joëlle Hajj, Dana Maslovat, Alexandra Leguerrier, and Victoria Smith
- Subjects
Male ,Reflex, Startle ,Physiology ,medicine.medical_treatment ,Movement ,Pyramidal Tracts ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Nuclear magnetic resonance ,medicine ,Reaction Time ,Humans ,030304 developmental biology ,Physics ,0303 health sciences ,General Neuroscience ,High intensity ,Reticulospinal tract ,Somatosensory Cortex ,Transcranial Magnetic Stimulation ,Transcranial magnetic stimulation ,Acoustic Stimulation ,Silent period ,Female ,030217 neurology & neurosurgery ,Research Article - Abstract
Corticospinal output pathways have typically been considered to be the primary driver for voluntary movements of the hand/forearm; however, more recently, reticulospinal drive has also been implicated in the production of these movements. Although both pathways may play a role, the reticulospinal tract is thought to have stronger connections to flexor muscles than to extensors. Similarly, movements involuntarily triggered via a startling acoustic stimulus (SAS) are believed to receive greater reticular input than voluntary movements. To investigate a differential role of reticulospinal drive depending on movement type or acoustic stimulus, corticospinal drive was transiently interrupted using high-intensity transcranial magnetic stimulation (TMS) applied during the reaction time (RT) interval. This TMS-induced suppression of cortical drive leads to RT delays that can be used to assess cortical contributions to movement. Participants completed targeted flexion and extension movements of the wrist in a simple RT paradigm in response to a control auditory go signal or SAS. Occasionally, suprathreshold TMS was applied over the motor cortical representation for the prime mover. Results revealed that TMS significantly increased RT in all conditions. There was a significantly longer TMS-induced RT delay seen in extension movements than in flexion movements and a greater RT delay in movements initiated in response to control stimuli compared with SAS. These results suggest that the contribution of reticulospinal drive is larger for wrist flexion than for extension. Similarly, movements triggered involuntarily by an SAS appear to involve greater reticulospinal drive, and relatively less corticospinal drive, than those that are voluntarily initiated.NEW & NOTEWORTHY Through the use of the transcranial magnetic stimulation-induced silent period, we provide novel evidence for a greater contribution of reticulospinal drive, and a relative decrease in corticospinal drive, to movements involuntarily triggered by a startle compared with voluntary movements. These results also provide support for the notion that both cortical and reticular structures are involved in the neural pathway underlying startle-triggered movements. Furthermore, our results indicate greater reticulospinal contribution to wrist flexion than extension movements.
- Published
- 2019
131. Ulysse ou le littéraire entre affect et raison
- Author
-
Louis-Thomas Leguerrier
- Subjects
Ulysse ,Affect ,Social Sciences and Humanities ,Benjamin Fondane ,Jérusalem ,Sciences Humaines et Sociales ,Odysseus ,Athens ,Raison ,Reason ,Athènes ,Jerusalem ,James Joyce - Abstract
Bien plus qu’une activité consistant à représenter des idées préconçues ou à consolider des récits historiques en compétition avec d’autres récits sur le marché du savoir, la création littéraire permet la confrontation de l’esprit humain avec ce qui le dépasse, ce qui l’appelle tout en lui échappant. Un des plus vieux récits de la tradition occidentale illustre de manière frappante cette confrontation de l’esprit avec l’inconnu. Il s’agit du célèbre épisode de l’Odyssée d’Homère où Ulysse, à l’approche de l’île des Sirènes, se ligote au mat de son navire afin de pouvoir écouter leur chant sans craindre d’y succomber et de sauter à l’eau pour les rejoindre. Grâce à ce stratagème, Ulysse fait l’expérience d’un abandon de l’esprit à ce qui l’affecte de l’extérieur, le fascinant et menaçant de lui faire perdre la raison. Mais en même temps, et dans un même mouvement, il fait l’expérience d’une maitrise des affects par la force de la raison. À la fois stoïque et ouvert au débordement des affects, Ulysse incarne les extrêmes de l’esprit, le lieu où la tension entre affect et raison est portée à son comble. Si cette confrontation de l’esprit avec ce qui le dépasse est mise en scène dans les textes littéraires selon des modalités qui dépendent des conditions historiques de leur production, elle est aussi réactivée, au-delà de ces conditions historiques, chaque fois que l’esprit d’un lecteur, chaque fois que l’esprit d’une lectrice y trouve l’occasion d’une ouverture à ce qui l’excède et le fascine., Much more than an activity of representing preconceived ideas or consolidate historical narratives competing with other narratives on the knowledge market, literary production allows the confrontation of the human mind with what is beyond it, which call him while escaping him. One of the most ancient stories of the Western tradition strikingly illustrates this confrontation of the mind with the unknown. This is the famous episode of Homer’s Odyssey where Odysseus, at the approach of the island of Sirens, binds himself to the mat of his ship in order to listen to their song without fear of succumb and jump into the water to join them. Thanks to this stratagem, Odysseus experiences the surrender of the mind toward what affects him from the outside, fascinating and threatening to make him lose reason. But at the same time, and in the same movement, he experiences the domination of affects by the force of reason. Stoic, but at the same time open to the overflow of affects, Odysseus embodies the extremes of the mind, the place where the tension between affect and reason is carried to its height.
- Published
- 2019
- Full Text
- View/download PDF
132. Valve replacement in patients with critical aortic stenosis and depressed left ventricular function: predictors of operative risk, left ventricular function recovery, and long term outcome
- Author
-
Vaquette, B, Corbineau, H, Laurent, M, Lelong, B, Langanay, T, de Place, C, Froger-Bompas, C, Leclercq, C, Daubert, C, and Leguerrier, A
- Published
- 2005
133. Isolated left main coronary artery stenosis: long term follow up in 106 patients after surgery
- Author
-
d'Allonnes, F Revault, Corbineau, H, Le Breton, H, Leclercq, C, Leguerrier, A, and Daubert, C
- Published
- 2002
134. Simple Scoring System to Predict In‐Hospital Mortality After Surgery for Infective Endocarditis
- Author
-
Gatti, Giuseppe, Perrotti, Andrea, Obadia, Jean-François, Duval, Xavier, Iung, Bernard, Alla, François, Chirouze, Catherine, Selton-Suty, Christine, Hoen, Bruno, Sinagra, Gianfranco, Delahaye, François, Tattevin, Pierre, Le Moing, Vincent, Pappalardo, Aniello, Chocron, Sidney, Hoen, B., Duval, X., Alla, F., Bouvet, A., Briancon, S., Cambau, E., Celard, M., Chirouze, C., Danchin, N., Doco-Lecompte, T., Delahaye, F., Etienne, J., Iung, B., Le Moing, V., Obadia, J. F., Leport, C., Poyart, C., Revest, M., Selton-Suty, C., Strady, C., Tattevin, P., Vandenesch, F., Bernard, Y., Chocron, S., Plesiat, P., Abouliatim, I., De Place, C., Donnio, P. Y., Carteaux, J. P., Lion, C., Aissa, N., Baehrel, B., Jaussaud, R., Nazeyrollas, P., Vernet, V., Nataf, P., Chidiac, C., Aumaître, H., Frappier, J. M., Oziol, E., Sotto, A., Sportouch, C., Bes, M., Abassade, P., Abrial, E., Acar, C., Alexandra, J. F., Amireche, N., Amrein, D., Andre, P., Appriou, M., Arnould, M. A., Assayag, P., Atoui, A., Aziza, F., Baille, N., Bajolle, N., Battistella, P., Baumard, S., Ben Ali, A., Bertrand, J., Bialek, S., Bois Grosse, M., Boixados, M., Borlot, F., Bouchachi, A., Bouche, O., Bouchemal, S., Bourdon, J. L., Brasme, L., Bricaire, F., Brochet, E., Bruntz, J. F., Cady, A., Cailhol, J., Caplan, M. P., Carette, B., Cartry, O., Cazorla, C., Chamagne, H., Champagne, H., Chanques, G., Chastre, J., Chevalier, B., Chometon, F., Christophe, C., Cohen, A., Colin de Verdiere, N., DANELUZZI, VALERIA, David, L., De Lentdecker, P., Delcey, V., Deleuze, P., Donal, E., Deroure, B., Descotes-Genon, V., Didier Petit, K., Dinh, A., Doat, V., Duchene, F., Duhoux, F., Dupont, M., Ederhy, S., Epaulard, O., Evest, M., Faucher, J. F., FANTIN, BARBARA, Fauveau, E., Ferry, T., Fillod, M., Floch, T., Fraisse, T., Frapier, J. M., Freysz, L., Fumery, B., Gachot, B., Gallien, S., Gandjbach, I., Garcon, P., Gaubert, A., Genoud, J. L., Ghiglione, S., Godreuil, C., Grentzinger, A., Groben, L., Gherissi, D., Guéret, P., Hagege, A., Hammoudi, N., Heliot, F., Henry, P., Herson, S., Houriez, P., Hustache-Mathieu, L., Huttin, O., Imbert, S., Jaureguiberry, S., Kaaki, M., Konate, A., Kuhn, J. M., Kural Menasche, S., Lafitte, A., Lafon, B., Lanternier, F., Le Chenault, V., Lechiche, C., Lefèvre-Thibaut, S., Lefort, A., Leguerrier, A., Lemoine, J., Lepage, L., Lepouse', C., Leroy, J., Lesprit, P., Letranchant, L., Loisance, D., Loncar, G., Lorentz, C., Mabo, P., Magnin-Poull, I., May, T., Makinson, A., Man, H., Mansouri, M., Marxcon, O., Maroni, J. P., Masse, V., Maurier, F., Meyohas, M. C., Michel, P. L., Michelet, C., Mechaï, F., Merceron, O., Messika-Zeitoun, D., Metref, Z., Meyssonnier, V., Mezher, C., Micheli, S., Monsigny, M., Mouly, S., Mourvillier, B., Nallet, O., Noel, V., Papo, T., Payet, B., Pelletier, A., Perez, P., Petit, J. S., Philippart, F., Piet, E., Plainvert, C., Popovic, B., Porte, J. M., Pradier, P., Ramadan, R., Richemond, J., Rodermann, M., Roncato, M., Roigt, I., Ruyer, O., Saada, M., Schwartz, J., Simon, M., Simorre, B., Skalli, S., Spatz, F., Sudrial, J., Tartiere, L., Terrier De La Chaise, A., Thiercelin, M. C., Thomas, D., Thomas, M., Toko, L., Tournoux, F., Tristan, A., Trouillet, J. L., Tual, L., Vahanian, A., Verdier, F., Vernet Garnier, V., vidal, valentina, Weyne, P., Wolff, M., Wynckel, A., Zannad, N., Zinzius, P. Y., University hospital of Trieste, Marqueurs pronostiques et facteurs de régulations des pathologies cardiaques et vasculaires - UFC ( UR 3920) (PCVP / CARDIO), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Hôpital Louis Pradel [CHU - HCL], Hospices Civils de Lyon (HCL), Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM), CIC Bichat (CIC1425), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM), DHU FIRE Centre de compétence des maladies pulmonaires rares, Service de cardiologie, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Maladies chroniques, santé perçue, et processus d'adaptation (APEMAC), Université de Lorraine (UL), Service des maladies infectieuses et tropicales, Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], Service de Cardiologie [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Service des Maladies Infectieuses et Tropicales [Point-à-Pitre, Guadeloupe], CHU Pointe-à-Pitre/Abymes [Guadeloupe], Service des maladies infectieuses et réanimation médicale [Rennes] = Infectious Disease and Intensive Care [Rennes], CHU Pontchaillou [Rennes], Recherches Translationnelles sur le VIH et les maladies infectieuses endémiques et émergentes (TransVIHMI), Institut de Recherche pour le Développement (IRD)-Université de Yaoundé I-Université Cheikh Anta Diop [Dakar, Sénégal] (UCAD)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Dr Duval reports grants from Pfizer Inc (New York, NY) outside the submitted work, Association for the Study and Prevention of Infective Endocarditis Study Group–Association pour l’ Etude et la Prevention de l’Endocadite Infectieuse, Modèles et méthodes de l'évaluation thérapeutique des maladies chroniques (U738 / UMR_S738), Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Paris Diderot - Paris 7 (UPD7)-AP-HP - Hôpital Bichat - Claude Bernard [Paris]-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP), Département de Santé Publique [Paris], Institut de recherche en santé publique [Paris], Laboratoire Chrono-environnement - UFC (UMR 6249) (LCE), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Centre National de la Recherche Scientifique (CNRS)-Université de Franche-Comté (UFC), Centre Hospitalier Régional Universitaire [Besançon] (CHRU Besançon)-Hôpital Saint-Jacques, Centre Michel de Boüard - Centre de recherches archéologiques et historiques anciennes et médiévales (CRAHAM), Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-Centre National de la Recherche Scientifique (CNRS), Recherches Translationnelles sur le VIH et les maladies infectieuses (TransVIHMI), Université Montpellier 1 (UM1)-Institut de Recherche pour le Développement (IRD)-Université Cheikh Anta Diop [Dakar, Sénégal] (UCAD)-Universtié Yaoundé 1 [Cameroun]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Marqueurs pronostiques et facteurs de régulations des pathologies cardiaques et vasculaires - UFC ( EA 3920) (PCVP / CARDIO), Centre Hospitalier Régional Universitaire [Besançon] (CHRU Besançon)-Université de Franche-Comté (UFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Centre Hospitalier Régional Universitaire [Besançon] (CHRU Besançon)-Hôpital Jean Minjoz, Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Recherche pour le Développement (IRD)-Université Montpellier 1 (UM1)-Université Cheikh Anta Diop [Dakar, Sénégal] (UCAD)-Universtié Yaoundé 1 [Cameroun]-Université de Montpellier (UM), Centre d'Investigation Clinique Antilles Guyane, Inserm CIC1424, Recherches Translationnelles sur le VIH et les maladies infectieuses endémiques er émergentes (TransVIHMI), Modèles et méthodes de l'évaluation thérapeutique des maladies chroniques, Gatti, Giuseppe, Perrotti, Andrea, Obadia, Jean-Françoi, Duval, Xavier, Iung, Bernard, Alla, Françoi, Chirouze, Catherine, Selton-Suty, Christine, Hoen, Bruno, Sinagra, Gianfranco, Delahaye, Françoi, Tattevin, Pierre, Le Moing, Vincent, Pappalardo, Aniello, Chocron, Sidney, Hoen, B., Duval, X., Alla, F., Bouvet, A., Briancon, S., Cambau, E., Celard, M., Chirouze, C., Danchin, N., Doco-Lecompte, T., Delahaye, F., Etienne, J., Iung, B., Le Moing, V., Obadia, J. F., Leport, C., Poyart, C., Revest, M., Selton-Suty, C., Strady, C., Tattevin, P., Vandenesch, F., Bernard, Y., Chocron, S., Plesiat, P., Abouliatim, I., De Place, C., Donnio, P. Y., Carteaux, J. P., Lion, C., Aissa, N., Baehrel, B., Jaussaud, R., Nazeyrollas, P., Vernet, V., Nataf, P., Chidiac, C., Aumaître, H., Frappier, J. M., Oziol, E., Sotto, A., Sportouch, C., Bes, M., Abassade, P., Abrial, E., Acar, C., Alexandra, J. F., Amireche, N., Amrein, D., Andre, P., Appriou, M., Arnould, M. A., Assayag, P., Atoui, A., Aziza, F., Baille, N., Bajolle, N., Battistella, P., Baumard, S., Ben Ali, A., Bertrand, J., Bialek, S., Bois Grosse, M., Boixados, M., Borlot, F., Bouchachi, A., Bouche, O., Bouchemal, S., Bourdon, J. L., Brasme, L., Bricaire, F., Brochet, E., Bruntz, J. F., Cady, A., Cailhol, J., Caplan, M. P., Carette, B., Cartry, O., Cazorla, C., Chamagne, H., Champagne, H., Chanques, G., Chastre, J., Chevalier, B., Chometon, F., Christophe, C., Cohen, A., Colin de Verdiere, N., Daneluzzi, Valeria, David, L., De Lentdecker, P., Delcey, V., Deleuze, P., Donal, E., Deroure, B., Descotes-Genon, V., Didier Petit, K., Dinh, A., Doat, V., Duchene, F., Duhoux, F., Dupont, M., Ederhy, S., Epaulard, O., Evest, M., Faucher, J. F., Fantin, Barbara, Fauveau, E., Ferry, T., Fillod, M., Floch, T., Fraisse, T., Frapier, J. M., Freysz, L., Fumery, B., Gachot, B., Gallien, S., Gandjbach, I., Garcon, P., Gaubert, A., Genoud, J. L., Ghiglione, S., Godreuil, C., Grentzinger, A., Groben, L., Gherissi, D., Guéret, P., Hagege, A., Hammoudi, N., Heliot, F., Henry, P., Herson, S., Houriez, P., Hustache-Mathieu, L., Huttin, O., Imbert, S., Jaureguiberry, S., Kaaki, M., Konate, A., Kuhn, J. M., Kural Menasche, S., Lafitte, A., Lafon, B., Lanternier, F., Le Chenault, V., Lechiche, C., Lefèvre-Thibaut, S., Lefort, A., Leguerrier, A., Lemoine, J., Lepage, L., Lepouse', C., Leroy, J., Lesprit, P., Letranchant, L., Loisance, D., Loncar, G., Lorentz, C., Mabo, P., Magnin-Poull, I., May, T., Makinson, A., Man, H., Mansouri, M., Marxcon, O., Maroni, J. P., Masse, V., Maurier, F., Meyohas, M. C., Michel, P. L., Michelet, C., Mechaï, F., Merceron, O., Messika-Zeitoun, D., Metref, Z., Meyssonnier, V., Mezher, C., Micheli, S., Monsigny, M., Mouly, S., Mourvillier, B., Nallet, O., Noel, V., Papo, T., Payet, B., Pelletier, A., Perez, P., Petit, J. S., Philippart, F., Piet, E., Plainvert, C., Popovic, B., Porte, J. M., Pradier, P., Ramadan, R., Richemond, J., Rodermann, M., Roncato, M., Roigt, I., Ruyer, O., Saada, M., Schwartz, J., Simon, M., Simorre, B., Skalli, S., Spatz, F., Sudrial, J., Tartiere, L., Terrier De La Chaise, A., Thiercelin, M. C., Thomas, D., Thomas, M., Toko, L., Tournoux, F., Tristan, A., Trouillet, J. L., Tual, L., Vahanian, A., Verdier, F., Vernet Garnier, V., Vidal, Valentina, Weyne, P., Wolff, M., Wynckel, A., Zannad, N., Zinzius, P. Y., Marqueurs pronostiques et facteurs de régulations des pathologies cardiaques et vasculaires - UFC ( PCVP / CARDIO ), Université Bourgogne Franche-Comté ( UBFC ) -Université de Franche-Comté ( UFC ) -Centre Hospitalier Régional Universitaire [Besançon] ( CHRU Besançon ), Hospices Civils de Lyon ( HCL ), Infection, Antimicrobiens, Modélisation, Evolution ( IAME ), Université Paris Diderot - Paris 7 ( UPD7 ) -Université Paris 13 ( UP13 ) -Université Sorbonne Paris Cité ( USPC ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), CIC Bichat ( CIC1425 ), Assistance publique - Hôpitaux de Paris (AP-HP)-Institut National de la Santé et de la Recherche Médicale ( INSERM ), Assistance publique - Hôpitaux de Paris (AP-HP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Risques, maladies chroniques et société : des systèmes biologiques aux populations, Université Henri Poincaré - Nancy 1 ( UHP ), Centre Hospitalier Régional Universitaire [Besançon] ( CHRU Besançon ) -Hôpital Jean Minjoz, Centre Hospitalier Régional Universitaire de Nancy ( CHRU Nancy ), Recherches Translationnelles sur le VIH et les maladies infectieuses ( TransVIHMI ), Université Montpellier 1 ( UM1 ) -Université Cheikh Anta Diop ( UCAD ) -Universtié Yaoundé 1 (Cameroun)-Université de Montpellier ( UM ), Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC)-Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), and Université Cheikh Anta Diop [Dakar, Sénégal] (UCAD)-Institut de Recherche pour le Développement (IRD)-Université de Yaoundé I-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Université Montpellier 1 (UM1)
- Subjects
Male ,Time Factors ,[SDV]Life Sciences [q-bio] ,Infective endocarditi ,030204 cardiovascular system & hematology ,Logistic regression ,0302 clinical medicine ,Risk Factors ,pulmonary hypertension ,Odds Ratio ,Cardiac valvular surgery ,Hospital Mortality ,Prospective Studies ,030212 general & internal medicine ,Treatment outcome ,ComputingMilieux_MISCELLANEOUS ,Original Research ,Cardiovascular Surgery ,Framingham Risk Score ,Endocarditis ,[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologie ,Middle Aged ,Critical care ,Infective endocarditis ,Mortality ,Predictors ,Pulmonary hypertension ,Quality control ,Cardiology and Cardiovascular Medicine ,Cardiac surgery ,Europe ,Treatment Outcome ,Area Under Curve ,Female ,Mortality/Survival ,medicine.medical_specialty ,Renal function ,Risk Assessment ,Decision Support Techniques ,03 medical and health sciences ,Predictive Value of Tests ,medicine ,Humans ,Infectious Endocarditis ,quality control ,Cardiac Surgical Procedures ,Risk factor ,Aged ,Chi-Square Distribution ,Receiver operating characteristic ,infective endocarditis ,business.industry ,Odds ratio ,cardiac valvular surgery ,medicine.disease ,mortality ,Surgery ,critical care ,predictors ,Logistic Models ,ROC Curve ,[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie ,Valvular Heart Disease ,Multivariate Analysis ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,business ,Predictor - Abstract
Background Aspecific scoring systems are used to predict the risk of death postsurgery in patients with infective endocarditis ( IE ). The purpose of the present study was both to analyze the risk factors for in‐hospital death, which complicates surgery for IE , and to create a mortality risk score based on the results of this analysis. Methods and Results Outcomes of 361 consecutive patients (mean age, 59.1±15.4 years) who had undergone surgery for IE in 8 European centers of cardiac surgery were recorded prospectively, and a risk factor analysis (multivariable logistic regression) for in‐hospital death was performed. The discriminatory power of a new predictive scoring system was assessed with the receiver operating characteristic curve analysis. Score validation procedures were carried out. Fifty‐six (15.5%) patients died postsurgery. BMI >27 kg/m 2 (odds ratio [ OR ], 1.79; P =0.049), estimated glomerular filtration rate OR , 3.52; P IV ( OR , 2.11; P =0.024), systolic pulmonary artery pressure >55 mm Hg ( OR , 1.78; P =0.032), and critical state ( OR , 2.37; P =0.017) were independent predictors of in‐hospital death. A scoring system was devised to predict in‐hospital death postsurgery for IE (area under the receiver operating characteristic curve, 0.780; 95% CI, 0.734–0.822). The score performed better than 5 of 6 scoring systems for in‐hospital death after cardiac surgery that were considered. Conclusions A simple scoring system based on risk factors for in‐hospital death was specifically created to predict mortality risk postsurgery in patients with IE .
- Published
- 2017
- Full Text
- View/download PDF
135. Supporting Patients With Incurable Cancer: Backup Behavior in Multidisciplinary Cross-Functional Teams
- Author
-
Bronwen LeGuerrier, Alysa Fairchild, Sharon Watanabe, Karen P. Chu, Xanthoula Kostaras, Debra M. Hall-Lavoie, Amy Driga, Fleur Huang, Renée Schmitz, and Edith Pituskin
- Subjects
Palliative care ,Knowledge management ,media_common.quotation_subject ,MEDLINE ,Bone Neoplasms ,Care provision ,Task (project management) ,03 medical and health sciences ,0302 clinical medicine ,Nursing ,Backup ,Multidisciplinary approach ,0502 economics and business ,Humans ,Medicine ,Function (engineering) ,Carcinoma, Renal Cell ,media_common ,Patient Care Team ,Oncology (nursing) ,business.industry ,Health Policy ,Palliative Care ,05 social sciences ,Flexibility (personality) ,Middle Aged ,Kidney Neoplasms ,Oncology ,030220 oncology & carcinogenesis ,Female ,business ,050203 business & management - Abstract
Caring for patients with incurable cancer presents unique challenges. Managing symptoms that evolve with changing clinical status and, at the same time, ensuring alignment with patient goals demands specific attention from clinicians. With care needs that often transcend traditional service provision boundaries, patients who seek palliation commonly interface with a team of providers that represents multiple disciplines across multiple settings. In this case study, we explore some of the dynamics of a cross-disciplinary approach to symptom management in an integrated outpatient radiotherapy service model. Providers who care for patients with incurable cancer must rely on one another to secure delivery of the right services at the right time by the right person. In a model of shared responsibilities, flexibility in who does what and when can enhance overall team performance. Adapting requires within-team and between-team monitoring of task and function execution for any given patient. This can be facilitated by a common understanding of the purpose of the clinical team and an awareness of the particular circumstances surrounding care provision. Backup behavior, in which one team member steps in to help another meet an expectation that would otherwise not be fulfilled, is a supportive team practice that may follow naturally in high-functioning teams. Such team processes as these have a place in the care of patients with incurable cancer and help to ensure that individual provider efforts more effectively translate into improved palliation for patients with unmet needs.
- Published
- 2016
- Full Text
- View/download PDF
136. Foreknowledge of an impending startling stimulus does not affect the proportion of startle reflexes or latency of StartReact responses
- Author
-
Alexandra Leguerrier, Anthony N. Carlsen, and Neil M. Drummond
- Subjects
Adult ,Male ,Reflex, Startle ,medicine.medical_specialty ,Adolescent ,Movement ,Audiology ,Stimulus (physiology) ,Statistics, Nonparametric ,050105 experimental psychology ,Developmental psychology ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Moro reflex ,Reaction Time ,medicine ,Humans ,0501 psychology and cognitive sciences ,Muscle, Skeletal ,Electromyography ,General Neuroscience ,Trial Type ,05 social sciences ,Foreknowledge ,Biomechanical Phenomena ,Sensory input ,Knowledge ,Acoustic Stimulation ,Reflex ,Female ,Psychology ,030217 neurology & neurosurgery - Abstract
During a simple reaction time (RT) task, movements can be initiated early and involuntarily through presentation of a loud startling acoustic stimulus (SAS), a phenomenon termed the StartReact effect. In order to infer that activity in startle-related structures led to the early response triggering, it is important to observe a concurrent startle reflex in sternocleidomastoid. It is generally accepted that to consistently elicit a startle reflex, the SAS must be both intense and unpredictable. However, it remains unclear what effect explicit foreknowledge of an impending SAS has on the effectiveness of a SAS to elicit a startle reflex when preparing a motor response. To test this, participants completed two separate blocks of a simple RT task (counterbalanced order), where the control auditory go-signal was replaced with a SAS on 20 % of trials. In an unwarned block, knowledge of the trial type (SAS vs. control) was not provided in advance, while in a warned block, the trial type was forewarned. Results revealed that while foreknowledge of an impending SAS reduced the magnitude of the startle reflex, it did not affect the proportion of startle reflexes elicited or the magnitude of the StartReact effect. An increase in control trial RT was observed during the unwarned block, but only when it was performed first. These results indicate that preparation of a motor response leads to sufficiently increased activation in startle-related neural structures such that even with explicit knowledge of an upcoming SAS, participants are unable to proactively gate the upcoming sensory input.
- Published
- 2016
- Full Text
- View/download PDF
137. Late Outcomes of Transcatheter Aortic Valve Replacement in High-Risk Patients
- Author
-
Martine Gilard, Hélène Eltchaninoff, Patrick Donzeau-Gouge, Karine Chevreul, Jean Fajadet, Pascal Leprince, Alain Leguerrier, Michel Lievre, Alain Prat, Emmanuel Teiger, Thierry Lefevre, Didier Tchetche, Didier Carrié, Dominique Himbert, Bernard Albat, Alain Cribier, Arnaud Sudre, Didier Blanchard, Gilles Rioufol, Frederic Collet, Remi Houel, Pierre Dos Santos, Nicolas Meneveau, Said Ghostine, Thibaut Manigold, Philippe Guyon, Dominique Grisoli, Herve Le Breton, Stephane Delpine, Romain Didier, Xavier Favereau, Geraud Souteyrand, Patrick Ohlmann, Vincent Doisy, Gilles Grollier, Antoine Gommeaux, Jean-Philippe Claudel, Francois Bourlon, Bernard Bertrand, Marc Laskar, Bernard Iung, Michel Bertrand, Jean Cassagne, Jacques Boschat, Jean Rene Lusson, Pierre Mathieu, Yves Logeais, Jean-Paul Bessou, Bernard Chevalier, Arnaud Farge, Philippe Garot, Thomas Hovasse, Marie Claude Morice, Mauro Romano, Patrick Donzeau Gouge, Olivier Vahdat, Bruno Farah, Didier Carrie, Nicolas Dumonteil, Gérard Fournial, Bertrand Marcheix, Patrick Nataf, Alec Vahanian, Florence Leclercq, Christophe Piot, Laurent Schmutz, Pierre Aubas, A. du Cailar, A. Dubar, N. Durrleman, F. Fargosz, Gilles Levy, Eric Maupas, François Rivalland, G. Robert, Christophe Tron, Francis Juthier, Thomas Modine, Eric Van Belle, Carlo Banfi, Thierry Sallerin, Olivier Bar, Christophe Barbey, Stephan Chassaing, Didier Chatel, Olivier Le Page, Arnaud Tauran, Daniele Cao, Raphael Dauphin, Guy Durand de Gevigney, Gérard Finet, Olivier Jegaden, Jean-François Obadia, Farzin Beygui, Jean-Philippe Collet, Alain Pavie, Frédéric Collet, null Pecheux, null Bayet, Alain Vaillant, Jacques Vicat, Olivier Wittenberg, Rémi Houel, Patrick Joly, Roger Rosario, Patrice Bergeron, Jacques Bille, Richard Gelisse, Jean-Paul Couetil, Jean-Luc Dubois Rande, Delphine Hayat, Emilie Fougeres, Jean-Luc Monin, Gauthier Mouillet, Florence Arsac, Emmanuel Choukroun, Marina Dijos, Jean-Philippe Guibaud, Lionel Leroux, Nicolas Elia, null Descotes Genon, Sidney Chocron, François Schiele, Christophe Caussin, Alexandre Azmoun, Saïd Ghostine, Rémi Nottin, Ashok Tirouvanziam, Dominique Crochet, Régis Gaudin, Jean-Christian Roussel, Nicolas Bonnet, Franck Digne, Patrick Mesnidrey, Thierry Royer, Victor Stratiev, Jean-Louis Bonnet, Thomas Cuisset, Hervé Le Breton, Issal Abouliatim, Marc Bedossa, Dominique Boulmier, Jean Philippe Verhoye, Stéphane Delepine, Jean-Louis Debrux, Alain Furber, Frédéric Pinaud, Eric Bezon, Jean-Noel Choplain, Oliver Bical, Grégoire Dambrin, Philippe Deleuze, Arnaud Jegou, Jean-René Lusson, Kasra Azarnouch, Nicolas Durel, Andrea Innorta, Géraud Souteyrand, Yves Lienhart, Ricardo Roriz, Patrick Staat, Jean-Noël Fabiani, Antoine Lafont, Rachid Zegdi, Didier Heudes, Michel Kindo, Jean-Philippe Mazzucotelli, Michel Zupan, Calin Ivascau, Thérèse Lognone, Massimo Massetti, Rémy Sabatier, Bruno Huret, Philippe Hochart, Damien Bouchayer, François Gabrielle, Franck Pelissier, Guillaume Tremeau, François Bourlon, Gilles Dreyfus, Armand Eker, Yakoub Habib, Nicolas Hugues, Claude Mialhe, Olivier Chavanon, Paolo Porcu, and Gérald Vanzetto
- Subjects
medicine.medical_specialty ,Framingham Risk Score ,Transcatheter aortic ,business.industry ,Incidence (epidemiology) ,medicine.medical_treatment ,030204 cardiovascular system & hematology ,medicine.disease ,3. Good health ,Surgery ,03 medical and health sciences ,Stenosis ,0302 clinical medicine ,Valve replacement ,Aortic valve stenosis ,medicine ,030212 general & internal medicine ,Cardiology and Cardiovascular Medicine ,Risk assessment ,business ,Prospective cohort study - Abstract
BACKGROUND Transcatheter aortic valve replacement (TAVR) has revolutionized management of high-risk patients with severe aortic stenosis. However, survival and the incidence of severe complications have been assessed in relatively small populations and/or with limited follow-up. OBJECTIVES This report details late clinical outcome and its determinants in the FRANCE-2 (FRench Aortic National CoreValve and Edwards) registry. METHODS The FRANCE-2 registry prospectively included all TAVRs performed in France. Follow-up was scheduled at 30 days, at 6 months, and annually from 1 to 5 years. Standardized VARC (Valve Academic Research Consortium) outcome definitions were used. RESULTS A total of 4,201 patients were enrolled between January 2010 and January 2012 in 34 centers. Approaches were transarterial (transfemoral 73%, transapical 18%, subclavian 6%, and transaortic or transcarotid 3%) or, in 18% of patients, transapical. Median follow-up was 3.8 years. Vital status was available for 97.2% of patients at 3 years. The 3-year all-cause mortality was 42.0% and cardiovascular mortality was 17.5%. In a multivariate model, predictors of 3-year all-cause mortality were male sex (p = 2 of 4 (p < 0.001). Severe events according to VARC criteria occurred mainly during the first month and subsequently in < 2% of patients/year. Mean gradient, valve area, and residual aortic regurgitation were stable during follow-up. CONCLUSIONS The FRANCE-2 registry represents the largest database available on late results of TAVR. Late mortality is largely related to noncardiac causes. Incidence rates of severe events are low after the first month. Valve performance remains stable over time. (J Am Coll Cardiol 2016; 68: 1637-47) (C) 2016 by the American College of Cardiology Foundation.
- Published
- 2016
- Full Text
- View/download PDF
138. Prise en charge des patients diabétiques par les anesthésistes-réanimateurs. Enquête conduite dans un établissement hospitalier universitaire et un centre hospitalier privé
- Author
-
A.-M. Leguerrier, N. Fusco, P. Guetté, A. Le Dain, J.-M. Bertho, C. Aveline, and G. Godet
- Subjects
Gynecology ,03 medical and health sciences ,medicine.medical_specialty ,0302 clinical medicine ,Nutrition and Dietetics ,030202 anesthesiology ,business.industry ,Endocrinology, Diabetes and Metabolism ,Internal Medicine ,medicine ,030212 general & internal medicine ,Cardiology and Cardiovascular Medicine ,business - Abstract
Resume Notre but etait d’evaluer la prise en charge peri-operatoire des patients diabetiques par les medecins anesthesistes et verifier sa conformite aux recommandations professionnelles, enquete menee conjointement dans un Centre hospitalier universitaire (CHU) et un Centre hospitalier prive (CHP). La population etudiee a concerne des patients majeurs diabetiques connus, qu’ils soient non-insulines (type 2 [DT2]), ou insulino-traites (type 1 [DT1], ou DT2 insulines), devant beneficier d’une intervention chirurgicale programmee sur le CHU Pontchaillou de Rennes ou le CHP de Cesson-Sevigne. Le recueil des donnees a ete effectue pendant une periode de 3 mois a l’aide d’un questionnaire standardise, renseigne par l’anesthesiste ou l’interne en charge du patient. Les questionnaires etaient completes lors de la consultation anesthesique, au bloc operatoire, puis a la sortie du patient. Entre janvier et mars 2014, les questionnaires concernant 161 patients diabetiques ont ete recueillis : 117 patients DT2, et 44 patients DT1 ou DT2 insulines. L’exhaustivite globale, evaluee sur les donnees PMSI, est de 74%, mais avec une disparite selon les specialites chirurgicales. Quels que soient le type de diabete et la duree attendue du jeune postoperatoire, une majorite de patients ont une prise en charge conforme aux recommandations (suspension de la metformine, poursuite des autres antidiabetiques oraux et de l’insuline, apports glucoses, relais eventuel par insulinotherapie per- et post-operatoire). Ainsi, si la prise en charge anesthesique des patients diabetiques est complexe, parfois difficile, elle est globalement satisfaisante. Notre etude montre que les recommandations sont relativement bien appliquees par les anesthesistes-reanimateurs, qui peuvent s’appuyer sur des protocoles therapeutiques solides et largement diffuses dans les differents services.
- Published
- 2016
- Full Text
- View/download PDF
139. Résultats de la transplantation cardiaque : expérience de 233 greffes
- Author
-
Logeais, Yves, Lelong, Bernard, Langanay, Thierry, Corbineau, Hervé, Rioux, Claude, and Leguerrier, Alain
- Published
- 2003
- Full Text
- View/download PDF
140. Texte 6 : le rôle du diabétologue
- Author
-
Paul Valensi, Carole Ichai, Alexandre Ouattara, Bogdan Nicolescu-Catargi, Gaëlle Cheisson, Igor Tauveron, Emmanuel Cosson, Anne-Marie Leguerrier, Dan Benhamou, la Société francophone du diabète, and Sophie Jacqueminet
- Subjects
Gynecology ,03 medical and health sciences ,medicine.medical_specialty ,0302 clinical medicine ,Anesthesiology and Pain Medicine ,business.industry ,medicine ,030209 endocrinology & metabolism ,030204 cardiovascular system & hematology ,business ,3. Good health - Abstract
Resume Il convient d’adresser un patient a un diabetologue en perioperatoire dans plusieurs circonstances. En preoperatoire, le patient lui est adresse si un diabete est depiste ou si on constate un desequilibre glycemique (HbA1c 8 %). Pendant l’hospitalisation, il faut faire appel a un diabetologue si un diabete est decouvert, s’il existe un desequilibre glycemique malgre la prise en charge ou s’il survient des difficultes a la reprise du traitement anterieur. En postoperatoire et a distance de l’hospitalisation, tous les diabetiques qui ont une HbA1c > 8 % doivent beneficier d’une consultation avec un diabetologue.
- Published
- 2017
- Full Text
- View/download PDF
141. Five-Year Clinical Outcome and Valve Durability After Transcatheter Aortic Valve Replacement in High-Risk Patients
- Author
-
Romain, Didier, Hélène, Eltchaninoff, Patrick, Donzeau-Gouge, Karine, Chevreul, Jean, Fajadet, Pascal, Leprince, Alain, Leguerrier, Michel, Lièvre, Alain, Prat, Emmanuel, Teiger, Thierry, Lefevre, Didier, Tchetché, Didier, Carrié, Dominique, Himbert, Bernard, Albat, Alain, Cribier, Arnaud, Sudre, Didier, Blanchard, Gilles, Rioufol, Frederic, Collet, Remi, Houel, Pierre, Dos Santos, Nicolas, Meneveau, Said, Ghostine, Thibaut, Manigold, Philippe, Guyon, Thomas, Cuisset, Herve, Le Breton, Stephane, Delepine, Xavier, Favereau, Geraud, Souteyrand, Patrick, Ohlmann, Vincent, Doisy, Thérèse, Lognoné, Antoine, Gommeaux, Jean-Philippe, Claudel, Francois, Bourlon, Bernard, Bertrand, Bernard, Iung, and Martine, Gilard
- Subjects
Aged, 80 and over ,Heart Failure ,Male ,Time Factors ,Hemodynamics ,Aortic Valve Stenosis ,Survival Analysis ,Stroke ,Transcatheter Aortic Valve Replacement ,Treatment Outcome ,Risk Factors ,Humans ,Equipment Failure ,Female ,Registries ,Aged ,Follow-Up Studies ,Proportional Hazards Models - Abstract
The FRANCE-2 registry (French Aortic National Corevalve and Edwards) previously reported good early- and medium-term clinical and echocardiographic efficacy for transcatheter aortic valve replacement. We here report 5-year follow-up results from the registry.The registry includes all consecutive patients undergoing transcatheter aortic valve replacement for severe aortic stenosis in France. Follow-up is scheduled at 30 days, 6 months, then annually from 1 to 5 years. Clinical events were defined according to the Valve Academic Research Consortium criteria, and hemodynamic structural valve deterioration (SVD) was defined according to the consensus statement by the European Association of Percutaneous Cardiovascular Interventions.Between January 2010 and January 2012, 4201 patients were enrolled in 34 centers. Five-year vital status was available for 95.5% of patients; 88.1% had clinical evaluation or died. Overall, at 5 years, all-cause mortality was 60.8% (n=2478; 95% CI, 59.3% to 62.3%). The majority of cardiovascular events occurred in the first month after valve implantation, and incidence remained low thereafter, at2% per year up to 5 years, except for heart failure. The rate of heart failure was 14.3% at 1 year, then decreased over time to5% per year. In cumulative incidence function, the rates of severe SVD and moderate/severe SVD at 5 years were 2.5% and 13.3%, respectively. Mortality did not differ between patients with or without severe SVD (hazard ratio, 0.71; 95% CI, 0.47-1.07; P=0.1). Finally, in the population of patients with severe SVD, 1 patient (1.7%) experienced a stroke, and 8 patients presented ≥1 heart failure event (13.3%).The 5-year follow-up results of the FRANCE-2 registry represent the largest long-term data set available in a high-risk population. In surviving patients, the low rate of clinical events and the low level of SVD after 1 year support the long-term efficacy of transcatheter aortic valve replacement in both types of transcatheter prosthesis featuring in the registry.
- Published
- 2018
142. Investigating Differences in Reaction Time and Preparatory Activation as a Result of Varying Accuracy Requirements
- Author
-
Leguerrier, Alexandra R.
- Subjects
Movement ,Neural activation - Abstract
The preparation and initiation of movement has previously been described using a neural accumulation model; this model involves an increase of neural activation in the motor cortex (M1) from baseline to a subthreshold level following a warning signal, which is maintained until presentation of an imperative stimulus (IS). Activity then increases until reaching movement initiation threshold. This model predicts that variability in activation during preparation may influence reaction time (RT) and its variability. The purpose of this thesis project was to determine whether differences in RT/variability of RT during the completion of tasks with varying levels of complexity may be attributable to differences in neural excitability in M1. To test this prediction, transcranial magnetic stimulation (TMS) delivered concurrently with an IS was used to determine neural excitability for movements with different accuracy demands. It was hypothesized that higher accuracy demands would result in lowered amplitude and/or greater variability of neural activation, and consequently slower/more variable RT. Fifteen healthy participants completed a simple RT task involving a targeted wrist extension movement under three different accuracy conditions (easy, moderate, difficult). TMS was delivered concurrently with the IS on 50% of trials during each condition. While pilot testing showed RT differences between accuracy conditions (Appendix A), the data presented here failed to detect significant differences in RT latency (F(2, 28) = .074, p = .929) or variability (F(1.432, 20.053) = .633, p = .538) between conditions . Similarly, no difference in MEP amplitude was observed between difficulty conditions (F(2, 28) = 2.439, p = .106). However, a subset of participants (n = 7) did show significant RT increases between easy and hard conditions (t(6) = 2.531, p = .045), but this subset still failed to show differences in MEP amplitude (t(6) = 1.157, p = .291) or variability (t(6) = 1.545, p = .173), suggesting that preparatory levels at the IS may be similar for movements involving both high and low accuracy demands.
- Published
- 2018
- Full Text
- View/download PDF
143. Hemodynamic Results and Mid-term Follow-up of 850 19 to 23 mm Perimount Magna Ease Valves
- Author
-
Alain Leguerrier, Vito G. Ruggieri, Thierry Langanay, Erwan Flecher, Jean-Philippe Verhoye, Amedeo Anselmi, Hervé Corbineau, and Reda Belhaj Soulami
- Subjects
Pulmonary and Respiratory Medicine ,Aortic valve ,Male ,medicine.medical_specialty ,Time Factors ,medicine.medical_treatment ,Hemodynamics ,030204 cardiovascular system & hematology ,Prosthesis Design ,Prosthesis ,03 medical and health sciences ,0302 clinical medicine ,Postoperative Complications ,Valve replacement ,Risk Factors ,Retrospective analysis ,Medicine ,Humans ,Aged ,Retrospective Studies ,Aged, 80 and over ,Heart Valve Prosthesis Implantation ,business.industry ,Retrospective cohort study ,Aortic Valve Stenosis ,Recovery of Function ,Surgery ,Mid term follow up ,medicine.anatomical_structure ,Treatment Outcome ,030228 respiratory system ,Concomitant ,Aortic Valve ,Heart Valve Prosthesis ,Female ,Cardiology and Cardiovascular Medicine ,business - Abstract
Background Aortic valve replacement (AVR) in small aortic roots remains a surgical dilemma with a higher risk of patient-prosthesis mismatch (PPM). The Perimount Magna Ease aortic valve (PMEAV) represents an attractive device in such cases. We examined the early hemodynamic performance, the mid-term outcomes of the PMEAV, and the impact of PPM on outcome and functional class. Methods We performed a retrospective analysis of prospectively collected in-hospital data, and a prospective single-center follow-up of 849 patients who received a 19 to 23 mm PMEAV (2008–2014). Concomitant mitral or tricuspid replacement was the exclusion criterion. Early hemodynamic features were prospectively collected; mid-term follow-up was conducted according to current guidelines. Results Size of implanted prosthesis was 19 mm in 11.5% of patients, 21 mm in 36.9%, and 23 mm in 51.5%. Operative mortality was 4.5% (3.1% for isolated AVR). The rate of severe and moderate PPMs was significantly higher in the 19 mm group. Follow-up was 99.9% complete (3.7 ± 2 years). Actuarial freedom from structural valve deterioration (SVD) at 5 years was 99.1%. At stratified Kaplan–Meier's analysis, PPM and age Conclusion This series shows satisfactory clinical outcomes of the PMEAV implanted in small aortic annuli at mid-term follow-up. Although PPM may occur in smaller sizes, it has limited clinical impact, and it is not associated with mid-term mortality or worse functional class. Few SVD events are evidenced; nonetheless, limited follow-up duration and its methodology need to be considered.
- Published
- 2018
144. Péché originel et utopie dans « Tout » d’Ingeborg Bachmann et dans Le rêve d’un homme ridicule de Dostoïevski
- Author
-
Leguerrier, Louis-Thomas and Université de Montréal. Faculté des arts et des sciences. Département de littératures et de langues du monde
- Abstract
Cet article propose une lecture croisée, basée sur le thème du péché originel, de la nouvelle « Tout » d’Ingeborg Bachmann et du récit Le rêve d’un homme ridicule de Dostoïevski. Le péché originel, compris comme la chute du genre humain dans une spirale de malheur, est examiné à la lumière de son actualisation par les théories critiques de la raison (Chestov, Benjamin, Adorno) formulées en plein cœur du rationalisme triomphant de la modernité. À partir des textes de Bachmann et Dostoïevski, la découverte de la distinction entre bien et mal par les premiers humains est pensée en continuité avec le développement d’un langage qui inscrit en l’être humain et dans ses relations sociales la séparation entre la raison autonome et la nature réduite à une chose muette et dépourvue de substance. Cette séparation est définie comme fondement d’une guerre éternelle entre les humains et la nature ainsi qu’entre les humains eux-mêmes., This paper proposes a comparative reading, on the theme of the original sin, of the short story “All” by Ingeborg Bachmann and of The Dream of a Ridiculous Man by Dostoïevski. The original sin, understood as the fall of mankind in a spiral of affliction, is examined in light of its actualization by critical theories of reason (Shestov, Benjamin, Adorno), which were articulated against the backdrop of the triumph of rationalist modernity. In these stories by Bachmann and Dostoïevski, the discovery of the distinction between good and evil by the first humans is taught in continuity with the development of a language that inscribes in humans and in their social relations the separation between autonomous reason and nature, the latter being devoid of substance. This separation is defined as the basis of an eternal war between humans and nature as well as among humans themselves.
- Published
- 2018
145. Perioperative management of adult diabetic patients. Review of hyperglycaemia: definitions and pathophysiology
- Author
-
Alexandre Ouattara, Bogdan Nicolescu-Catargi, Igor Tauveron, Emmanuel Cosson, Paul Valensi, Carole Ichai, Anne-Marie Leguerrier, Gaëlle Cheisson, Dan Benhamou, Sophie Jacqueminet, ProdInra, Migration, AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre de Recherche Épidémiologie et Statistique Sorbonne Paris Cité (CRESS (U1153 / UMR_A_1125 / UMR_S_1153)), Institut National de la Recherche Agronomique (INRA)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital Jean Verdier [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Sorbonne Paris Cité (COMUE) (USPC), Centre Hospitalier Universitaire de Nice (CHU Nice), CHU Pontchaillou [Rennes], CHU Bordeaux [Bordeaux], Université de Bordeaux (UB), CHU Clermont-Ferrand, Université Clermont Auvergne [2017-2020] (UCA [2017-2020]), CHU Gabriel Montpied [Clermont-Ferrand], and Benhamou, Dan
- Subjects
Adult ,Ketoacidosis ,medicine.medical_specialty ,HbA1c ,Diabetic ketoacidosis ,endocrine system diseases ,medicine.medical_treatment ,Médecine humaine et pathologie ,030209 endocrinology & metabolism ,Stress hyperglycaemia ,Critical Care and Intensive Care Medicine ,Perioperative Care ,03 medical and health sciences ,0302 clinical medicine ,Insulin resistance ,Basal-bolus ,030202 anesthesiology ,Internal medicine ,Diabetes mellitus ,medicine ,Diabetes Mellitus ,Humans ,Perioperative ,[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology ,Perioperative management ,business.industry ,Diabetes ,Insulin ,nutritional and metabolic diseases ,General Medicine ,medicine.disease ,Pathophysiology ,3. Good health ,Anesthesiology and Pain Medicine ,Hyperglycemia ,Human health and pathology ,business ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology - Abstract
Working party approved by the French Society of Anaesthesia and Intensive Care Medicine (SFAR) and the French Society for the study of Diabetes (SFD); International audience; Diabetes mellitus is defined by chronic elevation of blood glucose linked to insulin resistance and/or insulinopaenia. Its diagnosis is based on a fasting blood-glucose level of ≥ 1.26 g/L or, in some countries, a blood glycated haemoglobin (HbA1c) level of > 6.5%. Of the several forms of diabetes, type-2 diabetes (T2D) is the most common and is found in patients with other risk factors. In contrast, type-1 diabetes (T1D) is linked to the autoimmune destruction of β-pancreatic cells, leading to insulinopaenia. Insulin deficiency results in diabetic ketoacidosis within a few hours. ‘Pancreatic’ diabetes develops from certain pancreatic diseases and may culminate in insulinopaenia. Treatments for T2D include non-insulin based therapies and insulin when other therapies are no longer able to control glycaemic levels. For T1D, treatment depends on long (slow)-acting insulin and ultra-rapid analogues of insulin administered according to a ‘basal-bolus’ scheme or by continuous subcutaneous delivery of insulin using a pump. For patients presenting with previously undiagnosed dysglycaemia, investigations should determine whether the condition corresponds to pre-existing dysglycaemia or to stress hyperglycaemia. The latter is defined as transient hyperglycaemia in a previously non-diabetic patient that presents with an acute illness or undergoes an invasive procedure. Its severity depends on the type of surgery, the aggressiveness of the procedure and its duration. Stress hyperglycaemia may lead to peripheral insulin resistance and is an independent prognostic factor for morbidity and mortality.
- Published
- 2018
- Full Text
- View/download PDF
146. Five-Year Clinical Outcome and Valve Durability After Transcatheter Aortic Valve Replacement in High-Risk Patients: FRANCE-2 Registry
- Author
-
Nicolas Meneveau, Said Ghostine, G. Rioufol, Dominique Himbert, Stéphane Delépine, Philippe Guyon, Jean Fajadet, Frederic Collet, Martine Gilard, Didier Carrié, Alain Cribier, Patrick Ohlmann, Arnaud Sudre, Pascal Leprince, Michel Lievre, Thierry Lefèvre, Pierre Dos Santos, Thérèse Lognoné, Bernard Bertrand, Alain Prat, Didier Tchetche, Xavier Favereau, Thibaut Manigold, Jean-Philippe Claudel, Bernard Albat, Alain Leguerrier, Patrick Donzeau-Gouge, Hélène Eltchaninoff, Géraud Souteyrand, Bernard Iung, Antoine Gommeaux, Thomas Cuisset, Francois Bourlon, Remi Houel, Emmanuel Teiger, Didier Blanchard, Karine Chevreul, Hervé Le Breton, Romain Didier, Vincent Doisy, Laboratoire d'Electronique et des Technologies de l'Information (CEA-LETI), Direction de Recherche Technologique (CEA) (DRT (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Grenoble Alpes (UGA), Optimisation des régulations physiologiques (ORPHY (EA 4324)), Université de Brest (UBO)-Centre Hospitalier Régional Universitaire de Brest (CHRU Brest)-Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Université de Brest (UBO), Clinique St Hilaire ( Service de Cardiologie, Rouen), Epidémiologie Clinique et Evaluation Economique Appliquées aux Populations Vulnérables (ECEVE (U1123 / UMR_S_1123)), AP-HP Hôpital universitaire Robert-Debré [Paris]-Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de cardiologie [CHU Pitié-Salpêtrière], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Pitié-Salpêtrière [APHP], Laboratoire Traitement du Signal et de l'Image (LTSI), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM), Evaluation et modélisation des effets thérapeutiques, Département biostatistiques et modélisation pour la santé et l'environnement [LBBE], Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS), Service de cardiologie [Toulouse], Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Hôpital de Rangueil, CHU Toulouse [Toulouse], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Institut de génétique humaine (IGH), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN), Institut National de la Recherche Agronomique (INRA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Bordeaux Ségalen [Bordeaux 2], Max Planck Institute for Chemistry (MPIC), Max-Planck-Gesellschaft, Nutrition, obésité et risque thrombotique (NORT), Institut National de la Recherche Agronomique (INRA)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre recherche en CardioVasculaire et Nutrition (C2VN), Service de cardiologie et maladies vasculaires [CHU de Rennes], CHU Pontchaillou [Rennes], Service de cardiologie, Hôpitaux Universitaires de Strasbourg, Commissariat à l'énergie atomique et aux énergies alternatives - Laboratoire d'Electronique et de Technologie de l'Information (CEA-LETI), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM)-AP-HP Hôpital universitaire Robert-Debré [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service Cardiologie [CHU Toulouse], Pôle Cardiovasculaire et Métabolique [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research (C2VN), Service de cardiologie et maladies vasculaires [Rennes] = Cardiac, Thoracic, and Vascular Surgery [Rennes], Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Université de Brest (UBO)-Université de Brest (UBO)-Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Institut National de la Santé et de la Recherche Médicale (INSERM)-AP-HP Hôpital universitaire Robert-Debré [Paris]-Université Paris Diderot - Paris 7 (UPD7), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hospices Civils de Lyon (HCL), Institut National de la Santé et de la Recherche Médicale (INSERM)-AP-HP Hôpital universitaire Robert-Debré [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Hôpital de Rangueil, CHU Toulouse [Toulouse]-CHU Toulouse [Toulouse], Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Institut National de la Recherche Agronomique (INRA), and Aix Marseille Université (AMU)-Institut National de la Recherche Agronomique (INRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Subjects
medicine.medical_specialty ,cardiology esc ,Transcatheter aortic ,definitions ,medicine.medical_treatment ,[SDV]Life Sciences [q-bio] ,030204 cardiovascular system & hematology ,outcomes ,03 medical and health sciences ,0302 clinical medicine ,Valve replacement ,Physiology (medical) ,medicine ,Long term outcomes ,implantation ,030212 general & internal medicine ,ComputingMilieux_MISCELLANEOUS ,european association ,High risk patients ,business.industry ,heart-failure ,medicine.disease ,3. Good health ,Surgery ,predictors ,society ,Heart failure ,Cardiovascular System & Cardiology ,transcatheter aortic valve replacement ,pathology ,Cardiology and Cardiovascular Medicine ,business ,heart valves ,long-term outcomes - Abstract
Background: The FRANCE-2 registry (French Aortic National Corevalve and Edwards) previously reported good early- and medium-term clinical and echocardiographic efficacy for transcatheter aortic valve replacement. We here report 5-year follow-up results from the registry. Methods: The registry includes all consecutive patients undergoing transcatheter aortic valve replacement for severe aortic stenosis in France. Follow-up is scheduled at 30 days, 6 months, then annually from 1 to 5 years. Clinical events were defined according to the Valve Academic Research Consortium criteria, and hemodynamic structural valve deterioration (SVD) was defined according to the consensus statement by the European Association of Percutaneous Cardiovascular Interventions. Results: Between January 2010 and January 2012, 4201 patients were enrolled in 34 centers. Five-year vital status was available for 95.5% of patients; 88.1% had clinical evaluation or died. Overall, at 5 years, all-cause mortality was 60.8% (n=2478; 95% CI, 59.3% to 62.3%). The majority of cardiovascular events occurred in the first month after valve implantation, and incidence remained low thereafter, at P =0.1). Finally, in the population of patients with severe SVD, 1 patient (1.7%) experienced a stroke, and 8 patients presented ≥1 heart failure event (13.3%). Conclusions: The 5-year follow-up results of the FRANCE-2 registry represent the largest long-term data set available in a high-risk population. In surviving patients, the low rate of clinical events and the low level of SVD after 1 year support the long-term efficacy of transcatheter aortic valve replacement in both types of transcatheter prosthesis featuring in the registry.
- Published
- 2018
- Full Text
- View/download PDF
147. Perioperative management of adult diabetic patients. Specific situations
- Author
-
Emmanuel Cosson, Bogdan Nicolescu-Catargi, Dan Benhamou, Gaëlle Cheisson, Paul Valensi, Carole Ichai, Sophie Jacqueminet, Alexandre Ouattara, Anne-Marie Leguerrier, Igor Tauveron, Benhamou, Dan, AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre de Recherche Épidémiologie et Statistique Sorbonne Paris Cité (CRESS (U1153 / UMR_A_1125 / UMR_S_1153)), Institut National de la Recherche Agronomique (INRA)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital Jean Verdier [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Sorbonne Paris Cité (COMUE) (USPC), Centre Hospitalier Universitaire de Nice (CHU Nice), CHU Pontchaillou [Rennes], CHU Bordeaux [Bordeaux], Université de Bordeaux (UB), CHU Clermont-Ferrand, Université Clermont Auvergne [2017-2020] (UCA [2017-2020]), CHU Gabriel Montpied [Clermont-Ferrand], and ProdInra, Migration
- Subjects
Adult ,medicine.medical_specialty ,medicine.medical_treatment ,Blood sugar ,Médecine humaine et pathologie ,030209 endocrinology & metabolism ,Context (language use) ,Critical Care and Intensive Care Medicine ,Perioperative Care ,03 medical and health sciences ,Basal-bolus ,0302 clinical medicine ,Pregnancy ,Diabetes mellitus ,Diabetes Mellitus ,medicine ,Humans ,Diabetes ,Perioperative ,Ambulatory surgery ,Gestational diabetes ,030212 general & internal medicine ,[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology ,business.industry ,Insulin ,General Medicine ,medicine.disease ,3. Good health ,Diabetes, Gestational ,Anesthesiology and Pain Medicine ,Ambulatory Surgical Procedures ,Emergency medicine ,Ambulatory ,Female ,Human health and pathology ,business ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology - Abstract
Working party approved by the French Society of Anaesthesia and Intensive Care Medicine (SFAR) and the French Society for the study of Diabetes (SFD); International audience; Ambulatory surgery can be carried out in diabetic patients. By using a strict organisational and technical approach, the risk of glycaemic imbalance is minimised, allowing the patients to return to their previous way of life more quickly. Taking into account the context of ambulatory surgery, with a same day discharge, the aims are to minimise the changes to antidiabetic treatment, to maintain adequate blood sugar control and to resume oral feeding as quickly as possible. The preoperative evaluation is the same as for a hospitalised patient and recent glycaemic control (HbA1c) is necessary. Perioperative management and the administration of treatment depend on the number of meals missed. The patient can return home after taking up usual feeding and treatment again. Hospitalisation is necessary if significant glycaemic imbalance occurs. In pregnancy, it is necessary to distinguish between known pre-existing diabetes (T1D or T2D) and gestational diabetes, defined as glucose intolerance discovered during pregnancy. During labour, blood sugar levels should be maintained between 0.8 and 1.4 g/L (4.4–8.25 mmol/L). Control of blood sugar levels is obtained by using a continuous administration of insulin using an electronic syringe (IVES) together with a glucose infusion. Post-partum, management depends on the type of diabetes: in T1D and T2D patients a basal-bolus scheme is restarted with decreased doses while in gestational diabetes insulin therapy is stopped after delivery. Antidiabetic treatment is again necessary if blood sugar levels remain > 1.26 g/L (7 mmol/L).
- Published
- 2018
- Full Text
- View/download PDF
148. Influence des saisons et des pressions atmosphériques sur la survenue de dissections aortiques et de ruptures d’anévrismes aortiques. Étude rétrospective et revue de la littérature
- Author
-
Kasdi, Reda, Corbineau, Hervé, Harmouche, Majid, Langanay, Thierry, De Latour, Bertrand Richard, Leguerrier, Alain, Flecher, Erwan, and Verhoye, Jean-Philippe
- Subjects
Aortic dissection ,Atmospheric pressure ,Cardiac surgery ,Aneurysm - Abstract
JCTCV:22(1), Objectives: To evaluate the influence of season and atmospheric pressure (AP) on the onset of aortic dissection (AD) and aortic aneurysm rupture (AAR). Methods: Admissions for AD and RAA between 1 January 1989 and 31 December 2016 were reviewed. Regional AP data were provided by Meteo-France. Results: A total of 886 cases of AD were admitted on 844 days. The mean patient age was 63.5 ± 14.2 years with a male:female ratio of 2:1. Mortality: 146 pts (16.5%), which was increased with age (OR = 1.036; 95% CI [1.021, 1.051]; p < 0.0001), as was unknown hypertension status (OR = 2.586; 95% CI [1.757, 3.805]; p < 0.0001). A total of 344 cases of AAR were admitted on 330 days. The mean patient age was 72.4 ± 11.3 years with a male:female ratio of 4.4:1. Mortality: 108pts (31.4%). Age increased mortality (OR = 1.06; 95% CI [1.035, 1.086]; p < 0.0001) as did an unknown hypertension status (OR = 3.428; 95% CI [1.941, 6.055]; p < 0.0001). There was no influence of season on AD or AAR onset or mortality. Days with low AP (OR = 1.008; 95% CI [1.001, 1.015]; p < 0.0182) and high monthly AP variability (OR = 1.073; 95% CI [1.037, 1.111]; p < 0.0001) increased the risk of AD and AAR. High monthly AP reduced the risk of AAR (OR = 0.962; 95% CI [0.938, 0.987]; p < 0.003). Conclusion: Low AP values and high AP variability should increase our vigilance toward the risk of AD and AAR, especially by improving blood pressure control. Mortality by AD and AAR could be reduced by improved screening for hypertension in the general population.
- Published
- 2018
- Full Text
- View/download PDF
149. Practical management of diabetes patients before, during and after surgery: A joint French diabetology and anaesthesiology position statement
- Author
-
Gaëlle Cheisson, Bogdan Catargi, Igor Tauveron, Emmanuel Cosson, Paul Valensi, Dan Benhamou, Carole Ichai, E. Bismuth, A.M. Leguerrier, Sophie Jacqueminet, Alexandre Ouattara, Centre de Recherche Épidémiologie et Statistique Sorbonne Paris Cité (CRESS (U1153 / UMR_A_1125 / UMR_S_1153)), Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de la Recherche Agronomique (INRA), CHU Bordeaux [Bordeaux], Hôpitaux Universitaires Paris Sud, CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Service de Réanimation polyvalente, Centre hospitalier de Chartres-Hôpital Louis Pasteur [Chartres], Université de Nice Sophia-Antipolis (UNSA), CHU Pontchaillou [Rennes], Institut National de la Santé et de la Recherche Médicale (INSERM), Service d'Endocrinologie-Diabétologie, CHU Clermont-Ferrand-CHU Gabriel Montpied [Clermont-Ferrand], CHU Clermont-Ferrand, UFR Médecine, Université Pierre et Marie Curie - Paris 6 (UPMC), Génétique, Reproduction et Développement (GReD), Centre National de la Recherche Scientifique (CNRS)-Université Clermont Auvergne [2017-2020] (UCA [2017-2020])-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Gabriel Montpied [Clermont-Ferrand], AP-HP Hôpital universitaire Robert-Debré [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hop Univ Pari Sud, Hop Bicetre, AP HP, Serv Anesthesie Reanimat Chirurg, 78 Rue Gen Leclerc, F-94275 Le Kremlin Bicetre, France, Partenaires INRAE, Institut National de la Recherche Agronomique (INRA)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpitaux Universitaires Paris Sud [AP-HP] (HUPS), and Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne [2017-2020] (UCA [2017-2020])-Centre National de la Recherche Scientifique (CNRS)
- Subjects
Position statement ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,[SDV]Life Sciences [q-bio] ,030209 endocrinology & metabolism ,030204 cardiovascular system & hematology ,Guidelines ,Anaesthesia ,03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,Diabetes mellitus ,Internal Medicine ,Diabetes Mellitus ,Medicine ,Humans ,ComputingMilieux_MISCELLANEOUS ,business.industry ,General surgery ,Diabetes ,Disease Management ,Diabetology ,Societe francaise d'anesthesie et de ,General Medicine ,medicine.disease ,3. Good health ,Societe francophone du diabete ,Joint (building) ,France ,reanimation ,business - Abstract
International audience
- Published
- 2018
- Full Text
- View/download PDF
150. AVIATOR: An open international registry to evaluate medical and surgical outcomes of aortic valve insufficiency and ascending aorta aneurysm
- Author
-
de Heer, Frederiek, primary, Kluin, Jolanda, additional, Elkhoury, Gebrine, additional, Jondeau, Guillaume, additional, Enriquez-Sarano, Maurice, additional, Schäfers, Hans-Joachim, additional, Takkenberg, Johanna J.M., additional, Lansac, Emmanuel, additional, Dinges, Christian, additional, Steindl, Johannes, additional, Ziller, Rosina, additional, De Kerchove, Laurent, additional, Benkacem, Taoufik, additional, Coulon, Corinne, additional, Kaddouri, Fadoua, additional, Vanoverschelde, Jean-Louis, additional, de Meester, Christophe, additional, Pasquet, Agnès, additional, Nijs, Jan, additional, Van Mosselvelde, Veerle, additional, Loeys, Bart, additional, Meuris, Bart, additional, Schepmans, Evi, additional, Van den Bossche, Klaartje, additional, Verbrugghe, Peter, additional, Goossens, Wenke, additional, Gutermann, Herbert, additional, Pettinari, Matteo, additional, El-Hamamsy, Ismail, additional, Lenoir, Marien, additional, Noly, Pierre-Emmanuel, additional, Tousch, Michael, additional, Shah, Pallav, additional, Boodhwani, Munir, additional, Rudez, Igor, additional, Baric, Davor, additional, Unic, Daniel, additional, Varvodic, Josip, additional, Gjorgijevska, Savica, additional, Vojacek, Jan, additional, Zacek, Pavel, additional, Karalko, Mikita, additional, Hlubocky, Jaroslav, additional, Novotny, Robert, additional, Slautin, Andrey, additional, Soliman, Said, additional, Arnaud-Crozat, Eric, additional, Boignard, Aude, additional, Fayad, Georges, additional, Bouchot, Olivier, additional, Albat, Bernard, additional, Leguerrier, Alain, additional, Doguet, Fabien, additional, Fuzellier, Jean-François, additional, Glock, Yves, additional, Fernandez, Guy, additional, Chatel, Didier, additional, Zeitoun, David Messika, additional, Jouan, Jérôme, additional, Di Centa, Isabelle, additional, Obadia, Jean-François, additional, Leprince, Pascal, additional, Houel, Rémi, additional, Bergoend, Eric, additional, Lopez, Stéphane, additional, Berrebi, Alain, additional, Tubach, Florence, additional, Lejeune, Stéphanie, additional, Monin, Jean-Luc, additional, Pousset, Sarah, additional, Mankoubi, Leila, additional, Noghin, Milean, additional, Diakov, Christelle, additional, Czytrom, Daniel, additional, Borger, Michael, additional, Aicher, Diana, additional, Theisohn, Frank, additional, Ferrero, Paolo, additional, Stoica, Serban, additional, Matuszewski, Maciej, additional, Yiu, Patrick, additional, Bashir, Mohamad, additional, Ceresa, Fabrizio, additional, Patane, Francesco, additional, De Paulis, Ruggero, additional, Chirichilli, Ilaria, additional, Masat, Mauro, additional, Antona, Carlo, additional, Contino, Monica, additional, Mangini, Andrea, additional, Romagnoni, Claudia, additional, Grigioni, Francesco, additional, Rosa, Rubina, additional, Okita, Yutaka, additional, Miyairi, Takeshi, additional, Kunihara, Takashi, additional, de Heer, Frederiek, additional, Koolbergen, Dave, additional, Marsman, Mandy, additional, Gökalp, Arjen, additional, Bekkers, Jos, additional, Duininck, Liesbeth, additional, Klautz, Robert, additional, Van Brakel, Thomas, additional, Arabkhani, Bardia, additional, Mecozzi, Gianclaudio, additional, Accord, Ryan, additional, Jasinski, Marek, additional, Aminov, Vladislav, additional, Svetkin, Mihail, additional, Kolesar, Adrian, additional, Sabol, František, additional, Toporcer, Tomas, additional, Bibiloni, Ignacio, additional, Rábago, Gregorio, additional, Alvarez-Asiain, Virginia, additional, Melero, Amaia, additional, Sadaba, Rafael, additional, Aramendi, José, additional, Crespo, Alejandro, additional, Porras, Carlos, additional, Evangelista Masip, Arturo, additional, Kelley, Shelagh, additional, Bavaria, Joseph, additional, Milewski, Rita, additional, Moeller, Patrick, additional, Wenger, Isaac, additional, Alger, Stan, additional, Alger, Aurelie, additional, and Leavitt, Katie, additional
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.